Inventor · disambiguated record
Kelsey H. Satterly
Also filed as: SATTERLY KELSEY H
5 granted patents·7 pending applications·3 citations·filing 2019–2023
69Inventor score
Files withIMPEL NEUROPHARMA INC5IMPEL PHARMACEUTICALS INC5IMPEL PHARMCEUTICALS INC1WOODWARD SPECIALTY LLC1
Top patents by PatentIndex Score
12 records- 0188US11185497B2Intranasal delivery of dihydroergotamine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2020·Granted Nov 30, 2021·2 cites·5 claims
- 0280US11278492B2Intranasal delivery of olanzapine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2019·Granted Mar 22, 2022·1 cites·24 claims
- 0373US2023364010A1Intranasal delivery of olanzapine by precision olfactory deviceIMPEL PHARMCEUTICALS INC·Filed 2023·Application pending·0 cites
- 0471US11752100B2Intranasal delivery of olanzapine by precision olfactory deviceIMPEL PHARMACEUTICALS INC·Filed 2022·Granted Sep 12, 2023·0 cites·33 claims
- 0571US2024252489A1Repeated administration of dihydroergotamine for treatment of frequent migraine headachesWOODWARD SPECIALTY LLC·Filed 2023·Application pending·0 cites
- 0670US2023301955A1Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's diseaseIMPEL PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0769US11690819B2Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's diseaseIMPEL PHARMACEUTICALS INC·Filed 2022·Granted Jul 4, 2023·0 cites·18 claims
- 0868US11517548B2Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's DiseaseIMPEL PHARMACEUTICALS INC·Filed 2019·Granted Dec 6, 2022·0 cites·15 claims
- 0968US2022105030A1Intranasal delivery of dihydroergotamine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2021·Application pending·0 cites
- 1058US2021236485A1Repeated administration of dihydroergotamine for treatment of frequent migraine headachesIMPEL NEUROPHARMA INC·Filed 2021·Application pending·0 cites
- 1156US2019209463A1Intranasal delivery of dihydroergotamine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2019·Application pending·0 cites
- 1254US2022296504A1Intranasal delivery of levodopa powder by precision olfactory deviceIMPEL PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kelsey H. Satterly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →